170831 ⎘
Detection or diagnosis of diseases Haematology
Sub-classes:DETECTION OF HEMOLYSIS USING A CHROMATOGRAPHIC ASSAY DEVICE
#2METHODS AND DEVICES FOR QUANTITATIVELY ESTIMATING THROMBOMODULIN
#3COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
#4MEASUREMENT OF REACTIVE OXYGEN SPECIES TO ASSESS RED BLOOD CELL QUALITY
#5SINGLE DOMAIN ANTIBODIES FOR THE DETECTION OF PLASMIN-CLEAVED VWF
#6CREATININE LATERAL FLOW ASSAY DEVICES AND METHODS OF PRODUCTION AND USE THEREOF
#7SYSTEMS AND METHODS TO MEASURE OCCLUSION OF BLOOD CELLS IN MICROFLUIDIC CHANNELS
#8SAMPLE INCLUDING PRO-ADM AS A THERAPY MONITORING MARKER FOR CRITCALLY ILL PATIENTS
#9Device for Patient-Specific Prognosis
#10HEMOGLOBIN G-MAKASSAR BINDING POLYPEPTIDES AND ANTIBODIES AND METHODS OF USING THE SAME
#11RAPID SCREENING FOR ELEVATED BILE ACIDS USING WHOLE BLOOD
#12EX VIVO ANALYTIC METHOD
#13ASSAY METHODS FOR SCREENING INHIBITORS OF SICKLE CELL DISEASE, ß-THALASSEMIA, OR SICKLE CELL ß-THALASSEMIA, OR A PHENOTYPE THEREOF
#14METHOD FOR QUANTIFYING AHSP PROTEIN AND ITS USE FOR PROGNOSING A HAEMOGLOBIN-RELATED DISORDER
#15Translational Activators, Including Methods of Discovery and Uses Thereof
#16Cilia Protein as Biomarkers and Methods of Use
#17SYSTEM AND METHOD FOR OPTICAL DETECTION OF HEMOGLOBIN VARIANTS, OXYGEN AFFINITY, AND DEOXYGENATION
#18PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM
#19TREATMENT OF CASTLEMAN DISEASE
#20RESTORING PHYSIOLOGY IN IRON-DEFICIENT ORGANISMS USING SMALL MOLECULES
#21NON-FIBRILLAR HEMOGLOBIN S OLIGOMERS AND METHODS TO IDENTIFY MODULATORS OF HEMOGLOBIN S POLYMERIZATION
#22COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING NEUTROPHIL-MEDIATED INFLAMMATORY DISEASE
#23BIOCHIP HAVING MICROCHANNEL PROVIDED WITH CAPTURING AGENT FOR PERFORMING CYTOLOGICAL ANALYSIS
#24CERAMIDE RATIOS AS PREDICTIVE AND THERAPEUTIC BIOMARKERS FOR LEUKEMIAS
#25NANO-RHEOLOGICAL BIOMARKERS FOR EARLY AND IMPROVED FOLLOW-UP OF PATHOLOGIES ASSOCIATED TO RBC DEFORMABILITY ALTERATION
#26ACOUSTO-THERMAL SHIFT ASSAY FOR LABEL-FREE PROTEIN ANALYSIS
#27Methods for Identifying Haemoglobin S or C in a Biological Sample and Kits Thereof
#28COMPOSITIONS AND METHODS FOR BLOOD ANEMIA DETECTION
#29AEROBIC GLYCOLYSIS AND HYPERMETABOLIC STATES
#30METHODS FOR DETERMINING PERSONALIZED FULL DOSE OF MELPHALAN IN REDUCED INTENSITY REGIMEN PRIOR TO HEMATOPOIETIC CELL TRANSPLANTATION
#31WASH REAGENT CONTAINING ALKOXYLATED FATTY ALCOHOL AND METHODS OF PRODUCTION AND USE THEREOF
#32GENETIC ABNORMALITIES IN PLASMA CELL DYSCRASIAS
#33DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE
#34METHOD FOR ASSISTING PREDICTION OF SHUNT TROUBLE AND KIT THEREFOR
#35METHOD FOR DETERMINING THE HAEMOGLOBIN CONTENT OF AN ERYTHROID CELL
#36Protein biomarkers for diseases associated with the contact activation system
#37METHOD AND DEVICE FOR DETERMINING RED BLOOD CELLS DEFORMABILITY
#38COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
#39TREATMENT AND DIAGNOSIS OF ANAEMIA
#40COMPOSITIONS AND METHODS ASSOCIATED WITH HAPTOGLOBIN RELATED PROTEIN
#41BIOCHIP HAVING MICROCHANNEL PROVIDED WITH CAPTURING AGENT FOR PERFORMING CYTOLOGICAL ANALYSIS
#42DNA ORIGAMI BEADS FOR FLUORESCENCE QUANTIFICATION IN MICROFLUIDICS
#43COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING NEUTROPHIL-MEDIATED INFLAMMATORY DISEASE
#44BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES
#45Device for whole blood cross flow filtration using a cannula needle
#46DEVICES, KITS, AND METHODS FOR MONITORING DISEASE STATES
#47PRO-ADM AS A THERAPY MONITORING MARKER FOR CRITCALLY ILL PATIENTS
#48Device for cross flow filtration
#49RAPID TEST FOR CELLULAR FIBRONECTIN
#50METHOD AND APPARATUS FOR PERFORMING HEMATOLOGIC ANALYSIS USING AN ARRAY-IMAGING SYSTEM FOR IMAGING AND ANALYSIS OF A CENTRIFUGED ANALYSIS TUBE
#51METHOD FOR GUIDANCE OF FLUID THERAPY BASED ON PROADRENOMEDULLIN
#52Antibodies to human erythroferrone and uses thereof
#53COTL1 protein involved in maintaining homeostasis of hematopoietic stem cell, and use thereof
#54ERYTHROPOIETIC ROLE OF RESIDENT MACROPHAGES IN HEMATOPOIETIC ORGANS
#55In Vitro Diagnosis Device and Uses Thereof
#56Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome
#57Kit for hemoglobin A1C quantitative analysis
#58Assay to measure factor Xa inhibitors
#59COMPOSITIONS AND METHODS FOR DIAGNOSING OR TREATING NEUTROPHIL-MEDIATED INFLAMMATORY DISEASE
#60Compositions and methods for detecting mutations in JAK2 nucleic acid
#61ERYTHROFERRONE AND ERFE POLYPEPTIDES AND METHODS OF REGULATING IRON METABOLISM
#62Genetic abnormalities in plasma cell dyscrasias
#63Identification of immunoglobulin free light chains by mass spectrometry
#64Restoring physiology in iron-deficient organisms using small molecules
#65Antibodies to human erythroferrone and uses thereof
#66Assay to diagnose and treat disorders of the alternative pathway of complement activation
#67Red blood cell dynamics for gastrointestinal evaluation
#68Treatment and Diagnosis of Hereditary Xerocytosis
#69METHODS FOR PREDICTING THE RESPONSIVENESS OF A PATIENT AFFECTED WITH MALIGNANT HEMATOLOGICAL DISEASE TO CHEMOTHERAPY TREATMENT AND METHODS OF TREATMENT OF SUCH DISEASE
#70Use of Viscoelastic Analysis for Predicting Massive Hemorrhage
#71Ligand
#72BISPECIFIC ANTIBODIES AGAINST CD3 EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES
#73Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer
#74Compositions and methods for diagnosis and treatment of metabolic syndrome
#75METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#76LOWERING IRON
#77EVALUATING METHOD, EVALUATING APPARATUS, EVALUATING PROGRAM PRODUCT, EVALUATING SYSTEM, AND TERMINAL APPARATUS
#78Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease
#79PREDICTING MORBIDITY ASSOCIATED WITH RED BLOOD CELL VOLUME VARIANCE
#80Genomic instability markers in Fanconi anemia
#81Identification of novel diagnostics and therapeutics by modulating RhoH
#82Anti-erythropoietin antibodies
#83METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-THALASSEMIA
#84April variants
#85Compositions and methods for diagnosis and treatment of metabolic syndrome
#86Method and apparatus for performing hematologic analysis using an array-imaging system for imaging and analysis of a centrifuged analysis tube
#87Methods and materials for treating hematological malignancies
#88Compositions and methods for detecting mutations in JAK2 nucleic acid
#89Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer
#90Point of care sickle cell test
#91Analysis method for supporting classification
#92Method for detecting risk factor for metabolic syndrome or hyperferritinemia
#93METHOD FOR EVALUATING SALIVARY ADIPONECTIN LEVEL AND KIT FOR MEASURING SALIVARY ADIPONECTIN LEVEL
#94Assay for nitrated and total hemopexin in fluid samples
#95Method for treating metabolic syndrome
#96Heptadecanoic acid supplement to human diet
#97Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome
#98Multiphase systems for diagnosis of sickle cell disease
#99Blood filtering device
#100Device for cross flow filtration
#101Blood analyzer and blood analyzing method
#102Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand
#103Method for detecting bilirubin using a fluorescent protein
#104RAPID TEST FOR CELLULAR FIBRONECTIN
#105Method of hemoglobin-F determination
#106Method for diagnosing a hemoglobin-related disorder
#107Methods of treating hemoglobinopathies
#108Antibody specifically binding to ANG2 and use thereof
#109Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients
#110METHOD OF TREATING IRON DEFICIENCY ANEMIA
#111Inhibitors of the CD95 signaling pathway for treatment of MDS
#112Methods and compositions for the treatment of β-thalassemia
#113Kits and methods for determining physiologic level(s) and/or range(s) of hemoglobin and/or disease state
#114In vitro diagnosis device and uses thereof
#115METHODS AND DEVICES FOR SAMPLE TESTING AND EVALUATION
#116METHOD AND PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND DIAGNOTIC OF ANEMIA OF INFLAMMATION
#117METHOD FOR CHARACTERISING PLASMA CELL ASSOCIATED DISEASES
#118SYSTEM AND METHOD FOR TARGETING RELEVANT RESEARCH ACTIVITY IN RESPONSE TO DIAGNOSTIC MARKER ANALYSES
#119Means and methods for the determination of (D)-2-hydroxyglutarate (D2HG) or (D)-2-hydroxyadipic acid
#120Methods for diagnosis, prognosis and methods of treatment
#121TELOMERASE REVERSE TRANSCRIPTASE DEFICIENCY AS DIAGNOSTIC MARKER OF MYELODYSPLASTIC SYNDROME
#122Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease
#123ALPHA-HEMOGLOBIN STABILIZING PROTEIN ANTIBODIES AND METHODS OF USE THEREOF
#124Expanding hematopoietic stem cells
#125Preparation and use of nucleated red blood cell simulating particles and hematology control mixtures
#126Methods for treating vaso-occlusive crisis using non-modified annexin V
#127Red blood cell dynamics for administering treatment for iron-deficiency anemia
#128Modulation of NR2F6 and methods and uses thereof
#129Moesin fragments associated with aplastic anemia
#130Systems and methods for determining antibody-mediated risk index
#131Methods for Diagnosis, Prognosis and Methods of Treatment
#132Ordered Assembly of Membrane Proteins During Differentiation of Erythroblasts
#133Expanding hematopoietic stem cells
#134Sickle confirm modified hemoglobin solubility test
#135Method for diagnosing a hemoglobin-related disorder
#136Methods for diagnosis of myelodysplastic syndromes (MDS)
#137Methods and compositions for the treatment and diagnosis of haemorrhagic conversion
#138BIOMARKER FOR THE MONITORING AND PROGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS
#139Compositions and methods for detecting mutations in JAK2 nucleic acid
#140Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease
#141Methods for diagnosis, prognosis and methods of treatment
#142Methods, Devices, and Systems for Glycated Hemoglobin Analysis
#143METHOD AND APPARATUS FOR PERFORMING HEMATOLOGIC ANALYSIS USING AN ARRAY-IMAGING SYSTEM FOR IMAGING AND ANALYSIS OF A CENTRIFUGED ANALYSIS TUBE
#144Method and apparatus for remotely performing hematologic analysis utilizing a transmitted image of a centrifuged analysis tube
#145Use application of sugar chain-recognizing receptor
#146Preparation and use of nucleated red blood cell simulating particles and hematology control mixtures
#147METHODS OF QUANTIFYING BIOMARKERS
#148METHOD OF USING CARBONIC ANHYDRASE TO DETECT HEMOLYSIS
#149CTGF AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
#150Methods for diagnosis, prognosis and methods of treatment
#151THERAPEUTIC AND DIAGNOSTIC AGENTS
#152DETECTING AND CONTROLLING ABNORMAL HEMATOPOIESIS
#153Biomarkers for predicting response to immunosuppressive therapy
#154Hemostatic effects of glucono-delta-lactone
#155Methods for Diagnosing and Treating Iron Dysregulation
#156Ordered Assembly of Membrane Proteins During Differentiation of Erythroblasts
#157Method for discriminating red blood cells from white blood cells by using forward scattering from a laser in an automated hematology analyzer
#158Diagnosis of conditions associated with decreased arginine bioavailability
#159MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF
#160Modulation of NR2F6 and methods and uses thereof
#161METHODS INVOLVING LEF-1 REGULATION AND USE OF LEF-1 OR COMPOUNDS ALTERING LEF-1 SIGNALLING FOR TREATING OR PREVENTING DISEASES
#162COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID
#163Methods for diagnosis, prognosis and methods of treatment
#164DETECTION OF HUMAN PLATELET ANTIGEN (HPA) ANTIBODIES
#165Means and method for diagnosing hemolytic anemia
#166THERAPEUTIC AND DIAGNOSTIC AGENTS
#167Panel cell used for granulocyte antibody detection
#168Methods for manipulating phagocytosis mediated by CD47
#169Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara)
#170Methods and kits for the diagnosis of sickle cell
#171Process of screening for alpha-thalassemia carrier using immunochromatographic strip test
#172Interleukin-15 antagonists for the treatment of anemia
#173THERAPEUTIC AND DIAGNOSTIC AGENTS
#174Methods for diagnosis of myelodysplastic syndromes (MDS)
#175Methods of detection of iron deficiency
#176Low hemoglobin concentration cell percentage and method of use in detection of iron deficiency
#177Methods for diagnosing and evaluating treatment of blood disorders
#178Therapeutic and diagnostic agents
#179Methods of diagnosing essential thrombocythemia
#180Diagnosis of conditions associated with decreased arginine bioavailability
#181Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692, 58874, 252, 304, 1980, 14717, 9941, 1941, 19310, or 17832
#182Diagnosis and treatment of fanconi's anemia
#183Diagnosis of anemia and optimizing treatment for heart repair
#184Assay